-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 14, Innovent Biopharmaceutical and Reindeer Medical jointly announced that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has officially written Orphan drug designation (Orphan Drug Designation, ODD) , for the treatment of relapsed/refractory multiple myeloma (R/R MM)
FDA orphan drug designation can help accelerate the clinical development and registration of drugs in the United States
(Original abridged)